Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 11-2013 | 11-2012 | 11-2011 | 11-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 102,992 | 117,174 | 132,630 | 90,842 |
| Receivables | N/A | 90,835 | 132,917 | 200,742 | 209,044 |
| Inventories | N/A | 132,227 | 171,605 | 164,180 | 195,936 |
| Income taxes - deferred | N/A | 762 | 228 | 9,020 | 8,204 |
| Other current assets | 0 | 11,612 | 7,121 | 7,016 | 3,876 |
| TOTAL | $N/A | $341,744 | $432,179 | $516,884 | $511,056 |
| Non-Current Assets | |||||
| PPE Net | N/A | 41,595 | 40,194 | 45,215 | 45,687 |
| Intangibles | 0 | 14,274 | 14,975 | 18,128 | 9,326 |
| Other Non-Current Assets | 0 | 6,583 | 23,929 | 13,476 | 14,913 |
| TOTAL | $N/A | $62,452 | $79,098 | $76,819 | $69,926 |
| Total Assets | $N/A | $404,196 | $511,277 | $593,703 | $580,982 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 85,957 | 100,086 | 190,482 | 178,430 |
| TOTAL | $N/A | $109,372 | $136,743 | $224,529 | $213,651 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 4,880 | 18,521 | 7,692 | 17,958 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $109,372 | $136,743 | $224,529 | $213,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 27,563 | 27,025 | 27,568 | 30,276 |
| Common Shares | N/A | 275 | 270 | 276 | 303 |
| Retained earnings | N/A | -19,965 | 18,808 | 9,165 | -16,152 |
| Other shareholders' equity | 0 | 2,123 | 863 | -1,337 | 496 |
| TOTAL | $N/A | $294,824 | $374,534 | $369,174 | $367,331 |
| Total Liabilities And Equity | $0 | $404,196 | $511,277 | $593,703 | $580,982 |